XBIT
Companies
NASDAQ
XBiotech Inc.
Health Care
$2.59
-$1.28 (-32.41%)
Price Chart
Overview
About XBIT
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
Market Cap
$205.3M
Volume
145.9K
Avg. Volume
125.1K
P/E Ratio
24.076925
Dividend Yield
0.00%
Employees
96.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.23
Moderate Correlation
Volatility
High (0.78)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, XBIT shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$205.3M
Volume145.9K
P/E Ratio24.08
Dividend Yield0.00%
Important Dates
Next Dividend
July 23, 2021Next Earnings
November 9, 2022Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025